As of July 2026, 25 paid clinical trials are recruiting in Weslaco, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Weslaco offers studies at sites including Texas Valley Clinical Research for conditions such as Obesity, Overweight, Breast Cancer, Diabetes Mellitus, Type 2. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Weslaco, TX at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Texas Valley Clinical Research | Obesity, Overweight, Diabetes Mellitus, Type 2 | 11 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 3 |
| Pulmonary and Sleep Center of the Valley | Myositis | 1 |
| Rio Grande Pain Team | Lumbar Spinal Stenosis | 1 |
| South Heart Clinic | Atrial Enlargement, Cardiotoxicity, Conduction Defect | 1 |
| Texas Oncology - Central/South Texas | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Texas Oncology - Weslaco | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 1 |
| Texas Oncology - Weslaco, Knapp Medical Plaza | Melanoma | 1 |
| Texas Oncology- Central South | Breast Cancer | 1 |
| Texas Valley Clinical Research, LLC | Cortisol Excess, Type 2 Diabetes | 1 |
| USOR - Texas Oncology | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
Recruiting trials in Weslaco grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 25 recruiting clinical trials in Weslaco, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Weslaco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Weslaco include Obesity (5), Overweight (5), Breast Cancer (2), Diabetes Mellitus, Type 2 (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Weslaco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Weslaco include Texas Valley Clinical Research, Texas Oncology - Central South, Pulmonary and Sleep Center of the Valley, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Weslaco are Diabetes & metabolic (10), Cancer & tumors (8), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.